SoftMedx Healthcare Limited (HKG:0648)
Hong Kong · Delayed Price · Currency is HKD 0.5700
+0.0100 (1.79%)
Sep 2, 2026, 3:29 PM HKT
SoftMedx Healthcare Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 60 | 395 | 124 | 124 | 124 | 124 | |
Market Cap Growth | -51.58% | 219.18% | 0% | 0% | 0% | 0% |
Enterprise Value | 35 | 418 | 416 | 400 | 358 | 358 |
Last Close Price | 0.56 | 3.72 | 7.60 | 7.60 | 7.60 | 7.60 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 5.03 | 56.90 | 0.38 | 9.90 | - | - |
PS Ratio | 0.90 | 5.80 | 2.27 | 2.41 | 3.67 | 72.92 |
PB Ratio | 1.86 | 14.43 | 50.45 | -0.38 | -0.36 | -0.38 |
P/TBV Ratio | 1.86 | 14.43 | 50.45 | - | - | - |
P/FCF Ratio | 3.17 | 73.26 | 31.92 | - | - | - |
P/OCF Ratio | 3.17 | 73.26 | 31.92 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.52 | 6.12 | 7.62 | 7.78 | 10.60 | 210.72 |
EV/EBITDA Ratio | 3.18 | 36.03 | 47.70 | 63.79 | - | - |
EV/EBIT Ratio | 3.34 | 36.23 | 48.65 | 66.17 | - | - |
EV/FCF Ratio | 1.84 | 77.35 | 107.31 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.46 | 13.86 | -0.90 | -0.80 | -0.84 |
Debt / EBITDA Ratio | 0.12 | 1.06 | 3.72 | 40.27 | - | - |
Debt / FCF Ratio | 0.07 | 2.34 | 8.77 | - | - | - |
Net Debt / Equity Ratio | -0.78 | -0.19 | 7.35 | -0.87 | -0.79 | -0.81 |
Net Debt / EBITDA Ratio | -2.42 | -0.44 | 2.07 | 45.10 | -30.40 | -12.62 |
Net Debt / FCF Ratio | -1.33 | -0.94 | 4.65 | -62.90 | -80.64 | -36.80 |
Asset Turnover | 1.36 | 1.32 | 0.99 | 1.27 | 1.54 | 0.07 |
Inventory Turnover | 8.63 | 8.93 | 9.52 | 12.59 | - | - |
Quick Ratio | 2.10 | 1.56 | 0.63 | 0.04 | 0.02 | 0.04 |
Current Ratio | 2.50 | 2.29 | 0.96 | 0.09 | 0.05 | 0.05 |
Return on Equity (ROE) | 43.36% | 46.55% | - | - | - | - |
Return on Assets (ROA) | 13.29% | 13.95% | 9.66% | 9.35% | -26.52% | -56.68% |
Return on Invested Capital (ROIC) | 117.89% | 39.58% | - | - | - | - |
Return on Capital Employed (ROCE) | 31.90% | 41.80% | 284.70% | -1.90% | 2.70% | 8.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 13.74% | 1.76% | 263.38% | 10.10% | -15.52% | -21.21% |
FCF Yield | 31.55% | 1.36% | 3.13% | -3.62% | -2.72% | -5.76% |
Buyback Yield / Dilution | -354.44% | -77.14% | - | - | - | - |